8-K
filed November 15, 2024, 6:59 PM ET
ticker RDNW
CIK 0001596961
other material
confidence high
sentiment neutral
materiality 0.75
RumbleOn sets record date for $10M rights offering; backstop by Stone House Capital
RideNow Group, Inc.
- Record date fixed as Nov 25, 2024 for proposed $10.0M rights offering to holders of Class A and Class B common stock.
- Subscription rights distributed pro rata; one right per share; price set as 20% discount to 30-day or 10-day VWAP.
- Stone House Capital Management will serve as backstop investor, agreeing to purchase unsubscribed shares.
- Supporting investors Mark Tkach and William Coulter will exercise their pro rata subscription rights.
- Rights offering to be made under effective shelf registration; final terms to be announced before commencement.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001596961-24-000110
- form_type
- 8-K
- ticker
- RDNW
- cik
- 0001596961
- company_name
- RideNow Group, Inc.
- filed_at
- 2024-11-15T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:08.917760+00:00
- generated_at
- 2026-05-29T23:46:52.826845+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001596961-24-000110
- json_url
- https://secwatch.observer/filing/0001596961-24-000110.json
- markdown_url
- https://secwatch.observer/filing/0001596961-24-000110.md
- text_url
- https://secwatch.observer/filing/0001596961-24-000110.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1596961/000159696124000110/0001596961-24-000110-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1596961/000159696124000110/rmbl-20241115.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
XMTR
Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M
Xometry, Inc.
June 2, 2026, 5:26 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
HYMC
Hycroft TRS shows $10B NPV at spot; 51-year mine life with 10.4M oz gold
HYCROFT MINING HOLDING CORP
June 2, 2026, 4:31 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
TTI
TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex
TETRA TECHNOLOGIES INC
June 2, 2026, 4:26 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CEG
Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase
Constellation Energy Corp
June 2, 2026, 4:15 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CNL Strategic Capital, LLC
Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks
CNL Strategic Capital, LLC
June 2, 2026, 4:04 PM ET
other_material
Items 1.01, 2.03, 5.07, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
INMB
INmune Bio reports statistically significant white matter MRI biomarker in Phase 2 Alzheimer's trial
Inmune Bio, Inc.
June 2, 2026, 4:00 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
QMCO
Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance
QUANTUM CORP /DE/
June 2, 2026, 10:41 AM ET
other_material
Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CELC
Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial
Celcuity Inc.
June 2, 2026, 8:10 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.